Indaptus Therapeutics Stock Investor Sentiment

INDP Stock  USD 0.84  0.03  3.45%   
Slightly above 62% of Indaptus Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Indaptus Therapeutics stock suggests that many investors are alarmed at this time. Indaptus Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Indaptus Therapeutics. Many technical investors use Indaptus Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
3 days ago at www.macroaxis.com         
Discretionary transaction by Michael Newman of tradable shares of Indaptus Therapeutics subject to R...
Macroaxis News
few days ago at news.google.com         
Indaptus Therapeutics looks to raise 2.25M in private placement - MSN
Google News at Macroaxis
few days ago at news.google.com         
Indaptus Therapeutics, Inc. announced that it expects to receive 2.246493 million in funding - Marke...
Google News at Macroaxis
few days ago at finance.yahoo.com         
Indaptus Therapeutics, Inc. Announces 2.25 Million Private Placement Priced At-The-Market Under Nasd...
Yahoo News
few days ago at gurufocus.com         
Indaptus Therapeutics, Inc. Announces 2. ...
Gurufocus Stories at Macroaxis
few days ago at seekingalpha.com         
Indaptus Therapeutics looks to raise 2.25M in private placement
seekingalpha News
over a week ago at gurufocus.com         
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
Gurufocus Stories at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 250 shares by Hayes William B of Indaptus Therapeutics at 355.2 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
INDP stock touches 52-week low at 0.81 amid market challenges - Investing.com
Google News at Macroaxis
over three weeks ago at seekingalpha.com         
Indaptus Therapeutics files to sell 1.94M shares of common stock
seekingalpha News
over a month ago at www.macroaxis.com         
Acquisition by Hayes William B of 12500 shares of Indaptus Therapeutics at 2.63 subject to Rule 16b-...
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Jeffrey Meckler of 42553 shares of Indaptus Therapeutics at 1.05 subject to Rule 16b-...
Macroaxis News
over a month ago at news.google.com         
Indaptus Therapeutics announces 2.135M registered direct offering - MSN
Google News at Macroaxis
over a month ago at globenewswire.com         
Indaptus Therapeutics, Inc. Announces 2.135 Million Registered Direct Offering and Concurrent Privat...
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
Indaptus Therapeutics, Inc. Announces 2. ...
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Indaptus Therapeutics that are available to investors today. That information is available publicly through Indaptus media outlets and privately through word of mouth or via Indaptus internal channels. However, regardless of the origin, that massive amount of Indaptus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Indaptus Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Indaptus Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Indaptus Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Indaptus Therapeutics alpha.

Indaptus Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.